Technical breakthrough

Technical breakthrough · 18. September 2019
Secondary antibodies: most frequently asked questions
Technical breakthrough · 16. September 2019
SYnAbs generates antibodies for epigenetic applications

Technical breakthrough · 02. July 2019
SYnAbs one-stop-shop offer: complete CAR-VHH-T design and manufacturing for immunotherapy
Technical breakthrough · 10. June 2019
Anti-VHH monoclonal antibodies for the detection, quantification, and purification of camelid antibodies

Technical breakthrough · 08. June 2019
Anti-guinea pig antibodies to boost your research on infetious diseases
Technical breakthrough · 27. April 2019
Cell-adhesion molecules (CAMs) antibodies: cadherin antibodies, selection antibodies, integrin antibodies, Ig-like CAM

Technical breakthrough · 20. April 2019
SYnAbs and Univercells announce strategic agreement on biosimilar. Anti-idiotype generation, custom immuno-assay development & validation.
Technical breakthrough · 16. April 2019
Limits of immunization site against poor immunogenic antigen targets Gold standard in immunization procedures in animal Intraperitoneal (IP) and intravenous (IV) injections are well-established immunization procedures for raising mouse antibodies, and are considered as gold standard. But in the particular case of poor immunogenic compounds or haptens (like peptides, polysaccharides, lipids, small molecules…), traditional strategies can fail to generate large panels of mAbs and finally get a...

Technical breakthrough · 12. April 2019
Anti-rabies monoclonal antibody for potency testing of vaccines: replacing in-vivo test by in-vitro assay
Technical breakthrough · 11. March 2019
SYnAbs generates custom monoclonal antibodies against synthetic peptide to early diagnose schizophrenia mental disorder

Show more